A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2018 at "Paediatric Drugs"
DOI: 10.1007/s40272-018-0290-4
Abstract: BackgroundMajor depressive disorder (MDD) is a serious illness in children and adolescents. Vilazodone is a selective serotonin reuptake inhibitor approved for MDD in adults. This study evaluated the efficacy, safety, and tolerability of vilazodone in… read more here.
Keywords: study; vilazodone day; placebo; double blind ... See more keywords